Effects of COVID-19 on Pregnancy

Dear Colleagues,

Starting from March 2020, a global pandemic of coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared by the World Health Organization. This required radical changes in the organization of the healthcare systems and the development of new strategies to counteract the diffusion and adverse outcomes of SARS-CoV-2 infection. Among different subpopulations, pregnant women need careful management because of their relatively immunosuppressed state and restricted respiratory capacity. This should be taken into account carefully, considering that poor reproductive and maternal–fetal outcomes were associated with other viral infections.

Based on this background, this Special Issue aims to present papers focusing on the symptoms and signs of COVID-19 in pregnant women, the effects of SARS-CoV-2 infection on early , mid-, and late-term pregnancies, the maternal–fetal transmission of the virus, the placental characteristics of pregnancies complicated by SARS-CoV-2 infection, the effects of SARS-CoV-2 infection on assisted reproduction technologies (ARTs), the organizational changes in healthcare environments involved in the management of pregnant women and/or women who are seeking pregnancy through ARTs, new therapeutic and vaccination strategies, and the impact of the current pandemic on the mode of providing obstetric care.

Dr. Alessandro Favilli
Dr. Simone Garzon
Dr. Antonio Simone Laganà
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.